Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Working Capital Ratio
42.32%
Quarterly · Period ending:
LCTX Working Capital Ratio
Latest reported42.32%period ending
Latest reported42.32%period ending
LCTX Quarterly Working Capital Ratio (96.15% → 42.32%)
Quarterly working capital ratio
High-resolution chart · PNG
LCTX working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 42.3216% | |
| 43.837% | |
| 42.4483% | |
| 36.6782% | |
| 36.4409% | |
| 33.0148% | |
| 32.698% | |
| 21.2612% | |
| 24.4305% | |
| 26.5719% | |
| 20.2744% | |
| 26.0002% | |
| 29.0443% | |
| 28.6471% | |
| 33.1697% | |
| 34.8995% | |
| 36.0023% | |
| 39.634% | |
| 36.9148% | |
| 45.3869% | |
| 48.0943% | |
| 45.3388% | |
| 33.5621% | |
| 31.0263% | |
| 34.512% | |
| 38.1176% | |
| 40.6645% | |
| 41.6783% | |
| 8.3064% | |
| 11.9386% | |
| 29.0635% | |
| 18.4027% | |
| 25.5249% | |
| 27.4614% | |
| 20.6325% | |
| 7.7583% | |
| 6.2037% | |
| 9.9588% | |
| 11.7828% | |
| 18.1699% | |
| 22.6634% | |
| 24.0133% | |
| 36.7367% | |
| 31.2637% | |
| 34.9353% | |
| 29.1829% | |
| 33.745% | |
| 7.4578% | |
| 20.5754% | |
| 6.2574% | |
| 1.7185% | |
| 13.2273% | |
| 34.333% | |
| 24.5676% | |
| 9.374% | |
| 21.831% | |
| 30.3377% | |
| 42.7913% | |
| 47.5864% | |
| 50.7765% | |
| 48.8855% | |
| 52.5362% | |
| 62.1195% | |
| 61.5322% | |
| 51.5527% | |
| 80.874% | |
| 83.4043% | |
| 76.1656% | |
| 8.4532% | |
| -226.01% | |
| -315.7681% | |
| -377.3008% | |
| -412.3406% | |
| -294.7638% | |
| -751.7653% | |
| -1,545.1219% | |
| -378.3703% | |
| -137.538% | |
| 0.4679% | |
| 37.4104% | |
| 56.9206% | |
| 73.6893% | |
| 62.5405% | |
| 53.6954% | |
| 59.4573% | |
| 66.6843% | |
| 80.0302% | |
| 89.8904% | |
| 91.1832% | |
| 89.5514% | |
| -194.7873% | |
| -114.1383% | |
| 49.9233% | |
| 62.8223% | |
| 59.0673% | |
| 79.2218% | |
| 31.342% | |
| 72.2292% | |
| 74.8352% | |
| -52.9988% |